I. Wilson

发表

Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)

John A. Bowden, Christina M. Jones, Christina M Jones, 2022, Metabolomics.

Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

P. Carmeliet, R. Deberardinis, V. Lagani, 2016, EMBO molecular medicine.

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

C. Weston, S. Curbishley, D. Adams, 2017, Gut.

The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study

I. Wilson, R. Plumb, L. Gethings, 2021, Metabolites.

Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation

D. Kell, S. O’Hagan, G. Warhurst, 2017, Scientific Reports.

Metabolic consequences for mice lacking Endosialin: LC–MS/MS-based metabolic phenotyping of serum from C56Bl/6J Control and CD248 knock‐out mice

I. Wilson, Emily G. Armitage, C. Buckley, 2021, Metabolomics.

Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management

R. Goodacre, W. Dunn, M. Witting, 2022, Metabolomics.

Proteomic consequences of the deletion of cytochrome P450 (CYP450) reductase in mice.

I. Wilson, R. Plumb, L. Gethings, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

High Throughput UHPLC-MS-Based Lipidomics Using Vacuum Jacketed Columns.

I. Wilson, R. Plumb, G. Isaac, 2021, Journal of proteome research.

High Throughput LC-MS Platform for Large Scale Screening of Bioactive Polar Lipids in Human Plasma and Serum

P. Townsend, A. Whetton, I. Wilson, 2022, Journal of proteome research.

The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652

M. Redinbo, I. Wilson, P. Butler, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

Evaluation of hybrid surface technology for the analysis of the B-group vitamins by LC-ESI-MS/MS.

I. Wilson, P. Rainville, Jinchuan Yang, 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation

M. Mcphail, G. Auzinger, N. Heaton, 2021, Hepatology.

M. Mcphail, M. Coen, I. Wilson, 2021, Hepatology.

Ensuring Fact-Based Metabolite Identification in Liquid Chromatography–Mass Spectrometry-Based Metabolomics

R. Goodacre, D. Raftery, G. Theodoridis, 2023, Analytical chemistry.

A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK)

M. Viant, W. Dunn, I. Wilson, 2023, Nature Protocols.

Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation

D. Kell, S. O’Hagan, G. Warhurst, 2017, Scientific Reports.

Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies

R. Goodacre, W. Dunn, D. Broadhurst, 2018, Metabolomics.

Is Current Practice Adhering to Guidelines Proposed for Metabolite Identification in LC-MS Untargeted Metabolomics? A Meta-Analysis of the Literature.

G. Theodoridis, I. Wilson, H. Gika, 2021, Journal of proteome research.

Investigation of the pharmacokinetics and metabolic fate of Fasiglifam (TAK-875) in male and female rats following oral and intravenous administration

R. Mortishire-Smith, I. Wilson, R. Plumb, 2023, Xenobiotica; the fate of foreign compounds in biological systems.

Advances in high throughput LC/MS based metabolomics: A review

I. Wilson, R. Plumb, G. Isaac, 2023, TrAC Trends in Analytical Chemistry.

The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice

R. Wehr, I. Wilson, I. Wilson, 2017, Biochemical pharmacology.

Hyphenated MS-based targeted approaches in metabolomics.

I. Wilson, G. Theodoridis, I. Wilson, 2017, The Analyst.

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

David B. Darr, I. Wilson, J. Roach, 2020, Proceedings of the National Academy of Sciences.

The pharmacokinetics and metabolism of diclofenac in chimeric humanized and murinized FRG mice

R. Wehr, I. Wilson, I. Wilson, 2018, Archives of Toxicology.

Improving LC/MS/MS-based bioanalytical method performance and sensitivity via a hybrid surface barrier to mitigate analyte - Metal surface interactions.

I. Wilson, R. Plumb, P. Rainville, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.